AI Verdict
KNSL has stronger fundamentals based on our AI analysis.
KNSL vs KNSA Fundamental Comparison
| Metric | KNSL | KNSA |
|---|---|---|
| Revenue | $1.9B | $677.6M |
| Net Income | $503.6M | $59.0M |
| Net Margin | 26.9% | 8.7% |
| ROE | 25.7% | 10.4% |
| ROA | 8.3% | 7.7% |
| Current Ratio | N/A | 3.79x |
| Debt/Equity | 0.11x | 0.00x |
| EPS | $21.65 | $0.75 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KNSL vs KNSA: Frequently Asked Questions
Is KNSL or KNSA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KNSL has stronger fundamentals. KNSL is rated STRONG BUY (88% confidence) while KNSA is rated HOLD (68% confidence). This is not investment advice.
How does KNSL compare to KNSA fundamentally?
Kinsale Capital Group, Inc. has ROE of 25.7% vs Kiniksa Pharmaceuticals International, plc's 10.4%. Net margins are 26.9% vs 8.7% respectively.
Which stock pays higher dividends, KNSL or KNSA?
KNSL has a dividend yield of N/A or no dividend while KNSA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KNSL or KNSA for long term?
For long-term investing, consider that KNSL has STRONG BUY rating with 88% confidence, while KNSA has HOLD rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KNSL vs KNSA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KNSL vs KNSA, the AI consensus favors KNSL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.